Table 1.
Organ Involvement | Prevalence of Organ Involvement | Manifestations | References |
---|---|---|---|
Lung involvement | more than 90% (With hilar and mediastinal lymph node) |
Dry cough, wheezing, dysponea, fatigue Acute: Pleural effusion, pericardial effusion, pneumothorax, and lymph-node Chronic: lung fibrosis and respiratory failure |
[80,81,82] |
Lymph node involvement | 20% of patients | Peripheral lymphadenopathy, affected lymph nodes are moderately swollen, and are usually not painful. | [83,84,85] |
Endocrine and exocrine involvement | Thyroid glands and parotid glands are usually affected in 20%–50% of cases | Thyroid dysfunction (5%), Parotid enlargement (5%–10%), hypothalamic-pituitary effects (for example, diabetes insipidus), | [86,87] |
Skin involvement | 20%–30% of patients | Erythema nodosum (most common), profuse sweating, nodules, papules and plaques. | [88,89] |
Eye involvement | more than 40% of patients | pain, photophobia, and hyperaemia, sometimes associated with the Löfgren syndrome | [90,91,92] |
Bone involvement | 1%–13% of patients | Osteoporosis and osteopenia are common, Nodular lesions, cystic lesions involving the joints, arthritis and arthralgia | [93,94,95] |
Upper respiratory tract | In most patients with systemic sarcoidosis | Larynx, nasopharynx and nose are affected | [96,97,98] |
Renal involvement | 5% | Renal calculi, nephrocalcinosis, interstitial nephritis, and kidney failure | [99,100] |
Cardiac involvement | 20%–27% of sarcoidosis | Heart failure, arrhythmias, syncope | [101,102] |
Neurological involvement or neurosarcoidosis | less than 10% of patients | Facial palsy, Meningeal inflammation, encephalopathy, vasculopathy, seizures, hydrocephalus, and mass lesions | [103,104] |
Liver and spleen involvement | 18% | Hepatosplenomegaly, intrahepatic cholestasis, and portal hypertension and altered liver function | [105,106,107] |